Looking At Amgen's Recent Unusual Options Activity
SA Spotlights Sector Leaders and Laggards for April
Eli Lilly Stock Has The Technicals: Will Q1 Earnings Deliver Fundamentals?
Price Over Earnings Overview: Eli Lilly
Option Care Health Upgraded at UBS on Valuation After Q1 Beat
Market Whales and Their Recent Bets on LLY Options
Eli Lilly Q1 2025 Earnings Preview
Sector Update: Health Care Stocks Decline Pre-Bell Wednesday
Leading And Lagging Sectors For April 30, 2025
Humana's Exit of Some 'Unprofitable' Medicare Plans Helps Fuel a Big Profit Beat
Netflix, Sherwin-Williams, AbbVie And More On CNBC's 'Final Trades'
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Wednesday Ahead of Key Economic Reports, Mix of Earnings
Johnson & Johnson Receives FDA Approval For IMAAVYTM, A New FcRn Blocker Offering Long-Lasting Disease Control In The Broadest Population Of People Living With Generalized Myasthenia Gravis
Humana Records Q1 Earnings Beat as Cost Concerns Abate
May's Must-See Financial Events: Apple & Nvidia Earnings, Berkshire Meeting, Interest Rate Decision, and More
Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
WeightWatchers Rises on Partnership With Eli Lilly to Enhance Zepbound Access
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday
UnitedHealth Group Analyst Ratings